New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer.
about
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published EvidenceRecent advances in the medical treatment of breast cancerBiosimilars for the Treatment of Cancer: A Systematic Review of Published EvidenceA phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients.Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia.Current status and future directions of cancer immunotherapy.
P2860
New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
New frontiers in oncology: bio ...... he treatment of breast cancer.
@en
type
label
New frontiers in oncology: bio ...... he treatment of breast cancer.
@en
prefLabel
New frontiers in oncology: bio ...... he treatment of breast cancer.
@en
P2860
P1476
New frontiers in oncology: bio ...... he treatment of breast cancer.
@en
P2093
Marc Thill
P2860
P304
P356
10.1586/14737140.2015.993318
P577
2014-12-25T00:00:00Z